| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 27,960 | 27,890 | 23,065 | 24,137 | | Cost of Revenue | 21,053 | 19,937 | 18,636 | 18,989 | | | Gross Profit | 6,907 | 7,953 | 4,429 | 5,148 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,120 | 1,047 | 971 | 747 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 3,487 | 3,594 | 3,596 | 3,499 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,300 | 3,312 | (138) | 902 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (15) | (15) | (29) | (212) | | Earnings Before Interest And Taxes | 2,285 | 3,297 | (167) | 882 | | Interest Expense | 3,029 | 3,145 | 2,980 | 3,069 | | Income Before Tax | (744) | 152 | (3,147) | (2,187) | | Income Tax Expense | (439) | (49) | (957) | (677) | | Minority Interest | (21) |
-
|
-
| 192 | | | | Net Income From Continuing Ops | (305) | 201 | (2,190) | (1,510) | | | Non-recurring Events | | Discontinued Operations | (704) | 1,142 | (235) | 4,847 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,030) | 1,343 | (2,425) | 3,337 | | Preferred Stock And Other Adjustments | (385) | (438) | (282) | (368) | | | Net Income Applicable To Common Shares | ($1,415) | $905 | ($2,707) | $2,969 |
|
0.02% Nasdaq 
0.01 (0.67%) 
Income Statement
